Novel HER-2 Targeted Therapies in Breast Cancer
Cancers · 23.12.2023 · 16 (1) · 87
DOI: 10.3390/cancers16010087 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.12.2023. Verfasst von Catarina Lopes Fernandes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Pedro Hispano Hospital, 4464-513 Matosinhos, Portugal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human epidermal growth factor 2 (HER-2)-positive breast cancer represents 15–20% of all breast cancer subtypes and has an aggressive biological behavior with worse prognosis. The development of HER-2-targeted therapies has changed the disease’s course, having a direct impact on survival rates and quality of life. Drug development of HER-2-targeting therapies is a prolific field, with numerous new therapeutic strategies showing survival benefits and gaining regulatory approval in recent years. Furthermore, the acknowledgement of the survival impact of HER-2-directed therapies on HER-2-low breast cancer has contributed even more to advances in the field. The present review aims to summarize the newly approved therapeutic strategies for HER-2-positive breast cancer and review the new and exploratory HER-2-targeted therapies currently under development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Department, Pedro Hispano Hospital, 4464-513 Matosinhos, Portugal.
- Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Zitieren
APA
Fernandes, C. L., Silva, D. J., & Mesquita, A. (2023). Novel HER-2 Targeted Therapies in Breast Cancer. Cancers, 16(1), 87. https://doi.org/10.3390/cancers16010087
Vancouver
Fernandes CL, Silva DJ, Mesquita A. Novel HER-2 Targeted Therapies in Breast Cancer. Cancers. 2023;16(1):87. doi:10.3390/cancers16010087
BibTeX
@article{Fernandes2023,
author = {Fernandes, Catarina Lopes and Silva, Diogo J and Mesquita, Alexandra},
title = {Novel HER-2 Targeted Therapies in Breast Cancer},
journal = {Cancers},
year = {2023},
volume = {16},
number = {1},
pages = {87},
doi = {10.3390/cancers16010087}
}
EUVIMED